CoChat

Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Hepatic insulin signalling involves insulin receptor substrates (Irs) 1/2, and is normally associated with the inhibition of gluconeogenesis and activation of lipogenesis. In diabetes and obesity, insulin no longer suppresses hepatic gluconeogenesis, while continuing to activate lipogenesis, a state referred to as ‘selective insulin resistance’. Here, we show that ‘selective insulin resistance’ is caused by the differential expression of Irs1 and Irs2 in different zones of the liver. We demonstrate that hepatic Irs2-knockout mice develop ‘selective insulin resistance’, whereas mice lacking in Irs1, or both Irs1 and Irs2, develop ‘total insulin resistance’. In obese diabetic mice, Irs1/2-mediated insulin signalling is impaired in the periportal zone, which is the primary site of gluconeogenesis, but enhanced in the perivenous zone, which is the primary site of lipogenesis. While hyperinsulinaemia reduces Irs2 expression in both the periportal and perivenous zones, Irs1 expression, which is predominantly in the perivenous zone, remains mostly unaffected. These data suggest that ‘selective insulin resistance’ is induced by the differential distribution, and alterations of hepatic Irs1 and Irs2 expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms12977

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 LIrs1KO and LIrs2KO mice exhibited insulin resistance and glucose intolerance under a HF diet. (a) Real-time RT–PCR analysis to determine the expression levels of Irs1 and Irs2 in liver biopsy specimens obtained from patients with NAFLD (n=30). (b) The expression levels of Irs1 and Irs2 in the livers obtained from mice on NC and HF diet (n=12–14). (c) Body weight gain in LIrs1KO and LIrs2KO mice on NC or a HF diet (n=9–20). (d–f) Insulin tolerance test (d), oral glucose tolerance test (e) and pyruvate tolerance test (f) in LIrs1KO and LIrs2KO mice on HF diet (n=13–20). (g) Expression levels of the gluconeogenic genes in the livers of LIrs1KO and LIrs2KO mice in the fasting and fed states (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 1 LIrs1KO and LIrs2KO mice exhibited insulin resistance and glucose intolerance under a HF diet. (a) Real-time RT–PCR analysis to determine the expression levels of Irs1 and Irs2 in liver biopsy specimens obtained from patients with NAFLD (n=30). (b) The expression levels of Irs1 and Irs2 in the livers obtained from mice on NC and HF diet (n=12–14). (c) Body weight gain in LIrs1KO and LIrs2KO mice on NC or a HF diet (n=9–20). (d–f) Insulin tolerance test (d), oral glucose tolerance test (e) and pyruvate tolerance test (f) in LIrs1KO and LIrs2KO mice on HF diet (n=13–20). (g) Expression levels of the gluconeogenic genes in the livers of LIrs1KO and LIrs2KO mice in the fasting and fed states (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 2 LIrs2KO, but not LIrs1KO, mice showed hepatic steatosis under a HF diet. (a,b) Representative gross appearance (a) and Oil Red O staining (b) (scale bar, 50 μm) of the liver in LIrs1KO and LIrs2KO mice on NC or a HF diet. (c) TG content of the liver in LIrs1KO mice on NC or a HF diet (n=5–6). (d) de novo lipogenesis in the livers of LIrs1KO mice on a HF diet (n=3–4). (e) TG content of the liver in LIrs2KO mice on NC or a HF diet (n=5–6). (f) de novo lipogenesis in the livers of LIrs2KO mice on a HF diet (n=3–4). (g) Expression levels of SREBP1c, ACC and FAS genes in the livers of LIrs1KO and LIrs2KO mice under the fasting and fed states (n=5–6). (h) Expression levels of PPARγ, FSP27 and CD36 genes in the livers of LIrs1KO and LIrs2KO mice in the fasting and fed states (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 2 LIrs2KO, but not LIrs1KO, mice showed hepatic steatosis under a HF diet. (a,b) Representative gross appearance (a) and Oil Red O staining (b) (scale bar, 50 μm) of the liver in LIrs1KO and LIrs2KO mice on NC or a HF diet. (c) TG content of the liver in LIrs1KO mice on NC or a HF diet (n=5–6). (d) de novo lipogenesis in the livers of LIrs1KO mice on a HF diet (n=3–4). (e) TG content of the liver in LIrs2KO mice on NC or a HF diet (n=5–6). (f) de novo lipogenesis in the livers of LIrs2KO mice on a HF diet (n=3–4). (g) Expression levels of SREBP1c, ACC and FAS genes in the livers of LIrs1KO and LIrs2KO mice under the fasting and fed states (n=5–6). (h) Expression levels of PPARγ, FSP27 and CD36 genes in the livers of LIrs1KO and LIrs2KO mice in the fasting and fed states (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 3 LIrs1/2DKO mice showed severe insulin resistance and glucose intolerance, but inhibition of hepatic steatosis. (a) Body weights of LIrs1/2DKO mice on NC or a HF diet (n=9–10). (b–d) Insulin tolerance test (b), oral glucose tolerance test (c) and pyruvate tolerance test (d) in the LIrs1/2DKO mice on a HF diet (n=8–10). (e) Expression levels of the gluconeogenic genes in the livers of LIrs1/2DKO mice under the fasting and fed states (n=5–6). (f,g) Representative gross appearance (f) and Oil Red O staining (g) (scale bar, 50 μm) of the liver in the LIrs1/2DKO mice on a HF diet. (h) TG content of the liver in LIrs1/2DKO mice on HF diet (n=6). (i) Expression levels of SREBP1c, ACC and FAS genes in the livers of LIrs1/2DKO mice in the fasting and fed states (5–6). (j) Expression levels of PPARγ, FSP27 and CD36 genes in the livers of LIrs1/2DKO mice in the fasting and fed states (5–6). (k) Comparison of the phenotypes in subject with type 2 diabetes, LIrs1KO, LIrs2KO and LIrs1/2DKO mice. Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 3 LIrs1/2DKO mice showed severe insulin resistance and glucose intolerance, but inhibition of hepatic steatosis. (a) Body weights of LIrs1/2DKO mice on NC or a HF diet (n=9–10). (b–d) Insulin tolerance test (b), oral glucose tolerance test (c) and pyruvate tolerance test (d) in the LIrs1/2DKO mice on a HF diet (n=8–10). (e) Expression levels of the gluconeogenic genes in the livers of LIrs1/2DKO mice under the fasting and fed states (n=5–6). (f,g) Representative gross appearance (f) and Oil Red O staining (g) (scale bar, 50 μm) of the liver in the LIrs1/2DKO mice on a HF diet. (h) TG content of the liver in LIrs1/2DKO mice on HF diet (n=6). (i) Expression levels of SREBP1c, ACC and FAS genes in the livers of LIrs1/2DKO mice in the fasting and fed states (5–6). (j) Expression levels of PPARγ, FSP27 and CD36 genes in the livers of LIrs1/2DKO mice in the fasting and fed states (5–6). (k) Comparison of the phenotypes in subject with type 2 diabetes, LIrs1KO, LIrs2KO and LIrs1/2DKO mice. Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 4 Insulin signalling was impaired in the hepatic PP zone, but enhanced in the hepatic PV zone under the HF diet condition. (a) Expression levels of genes for gluconeogenesis and lipid synthesis and storage in the hepatic PP and PV zones of mice on NC diet-fed mice in the fasting state (n=4–6). (b) mRNA expression levels of IR, Irs1, Irs2, Akt1 and Akt2 in the hepatic PP and PV zones of NC diet-fed mice under the fasting state (n=4). (c) Protein levels of IR Irs1, Irs2 and Akt in the hepatic PP and PV zone of NC diet-fed mice in the fasting state (n=4–5). (d) The expression levels of IR, Irs1 and Irs2 mRNA in the hepatic PP and PV zones of NC- or HF diet-fed mice under the fasting state (n=7–9). (e,f) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP (e) and PV (f) zones of NC- or HF diet-fed mice under the fasting state (n=6–8). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 4 Insulin signalling was impaired in the hepatic PP zone, but enhanced in the hepatic PV zone under the HF diet condition. (a) Expression levels of genes for gluconeogenesis and lipid synthesis and storage in the hepatic PP and PV zones of mice on NC diet-fed mice in the fasting state (n=4–6). (b) mRNA expression levels of IR, Irs1, Irs2, Akt1 and Akt2 in the hepatic PP and PV zones of NC diet-fed mice under the fasting state (n=4). (c) Protein levels of IR Irs1, Irs2 and Akt in the hepatic PP and PV zone of NC diet-fed mice in the fasting state (n=4–5). (d) The expression levels of IR, Irs1 and Irs2 mRNA in the hepatic PP and PV zones of NC- or HF diet-fed mice under the fasting state (n=7–9). (e,f) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP (e) and PV (f) zones of NC- or HF diet-fed mice under the fasting state (n=6–8). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 5 Insulin signaling was impaired in the PP and PV zones in the LIrs1KO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP zone of the LIrs1KO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 5 Insulin signaling was impaired in the PP and PV zones in the LIrs1KO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP zone of the LIrs1KO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs1KO mice in the fasting state (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 6 Insulin signaling was impaired only in the PP zone in the LIrs2KO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP zone of the LIrs2KO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 6 Insulin signaling was impaired only in the PP zone in the LIrs2KO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR Irs1, Irs2 and Akt in the hepatic PP zone of the LIrs2KO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs2KO mice in the fasting state (n=5–6). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 7 Insulin signalling was impaired in both the PP and PV zones of the liver in the LIrs1/2DKO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR, Irs1, Irs2 and Akt in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of the LIrs1/2DKO mice in the fasting state (n=4–10). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=4–10). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=4–10). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 7 Insulin signalling was impaired in both the PP and PV zones of the liver in the LIrs1/2DKO mice under the HF diet condition. (a) Phosphorylation and protein levels of IR, Irs1, Irs2 and Akt in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=6–8). (b) Expression levels of the gluconeogenic genes in the hepatic PP and PV zones of the LIrs1/2DKO mice in the fasting state (n=4–10). (c) Expression levels of SREBP1c, ACC and FAS genes in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=4–10). (d) Expression levels of PPARγ, FSP27 and CD36 genes in the hepatic PP and PV zones of LIrs1/2DKO mice in the fasting state (n=4–10). Results are represented as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001, (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 8 Irs1 expression was regulated by β-catenin/TCF4 signalling. (a,b) mRNA (a) and protein (b) expression levels of β-catenin, TCF4, Irs1 and Irs2 in H4IIE cells transfected with siβ-catenin (n=6–8). (c,d) mRNA (c) and protein (d) expression levels of β-catenin, TCF4, Irs1 and Irs2 in H4IIE cells transfected with siTCF4 (n=6–8). (e) Induction of mouse Irs1 promoter activity by the TCF/LEF response element. Results from the representative (n=6) of three replicated experiments is shown. (f) Two adjacent TCF/LEF motifs were present within the nucleotide region between −7,000 and −5,966 in the murine Irs1 promoter. Endogenous β-catenin or TCF4 chromatin immunoprecipitation with primers against the indicated regions of murine Irs1. GS was used as the positive control region (n=4). The primer sequences are highlighted (bold and underlined). Red text indicates putative TCF4-binding sites. Results are expressed as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001 (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).
Figure 8 Irs1 expression was regulated by β-catenin/TCF4 signalling. (a,b) mRNA (a) and protein (b) expression levels of β-catenin, TCF4, Irs1 and Irs2 in H4IIE cells transfected with siβ-catenin (n=6–8). (c,d) mRNA (c) and protein (d) expression levels of β-catenin, TCF4, Irs1 and Irs2 in H4IIE cells transfected with siTCF4 (n=6–8). (e) Induction of mouse Irs1 promoter activity by the TCF/LEF response element. Results from the representative (n=6) of three replicated experiments is shown. (f) Two adjacent TCF/LEF motifs were present within the nucleotide region between −7,000 and −5,966 in the murine Irs1 promoter. Endogenous β-catenin or TCF4 chromatin immunoprecipitation with primers against the indicated regions of murine Irs1. GS was used as the positive control region (n=4). The primer sequences are highlighted (bold and underlined). Red text indicates putative TCF4-binding sites. Results are expressed as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001 (Student's t-test was used to analyse the statistical significances of differences between two groups, and analysis of variance for the statistical significances of differences among multiple groups).CC BY · PubMed Central
Figure 9 Scheme illustrating the mechanism of ‘selective insulin resistance' in type 2 diabetes with obesity. In type 2 diabetes with obesity, while the hepatocyte Irs1 expression levels remain unaffected by the hyperinsulinemia, the expression of Irs2 is downregulated in both the PP and PV zones. Thus, in the PP zone, where Irs1 is less abundantly expressed and Irs2 expression is downregulated, insulin signaling is impaired despite the hyperinsulinemia, leading to the impaired suppression of gluconeogenesis and hyperglycaemia; in contrast, in the PV zone, where Irs1 is abundantly expressed, insulin signaling is rather stimulated in the presence of hyperinsulinemia despite the downregulation of Irs2, resulting in the increased lipogenesis and development of steatosis.
Figure 9 Scheme illustrating the mechanism of ‘selective insulin resistance' in type 2 diabetes with obesity. In type 2 diabetes with obesity, while the hepatocyte Irs1 expression levels remain unaffected by the hyperinsulinemia, the expression of Irs2 is downregulated in both the PP and PV zones. Thus, in the PP zone, where Irs1 is less abundantly expressed and Irs2 expression is downregulated, insulin signaling is impaired despite the hyperinsulinemia, leading to the impaired suppression of gluconeogenesis and hyperglycaemia; in contrast, in the PV zone, where Irs1 is abundantly expressed, insulin signaling is rather stimulated in the presence of hyperinsulinemia despite the downregulation of Irs2, resulting in the increased lipogenesis and development of steatosis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Benhamouche, S. et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev. Cell. 10, 759–770 (2006). · DOI · Paper page

Cited by

See all 143

Metadata

Authors
Kubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., Kohjima, M., Nakamuta, M., Moroi, M., Sugi, K., Noda, T., Terauchi, Y., Ueki, K., & Kadowaki, T.
Affiliations
  • National Institute of Biomedical Innovation, Health and Nutrition (JP)
  • Toho University (JP)
  • The University of Tokyo (JP)
  • Hokkaido University (JP)
  • Tokyo Medical University (JP)
  • National Kyushu Medical Center (JP)
  • Japanese Foundation For Cancer Research (JP)
  • Yokohama City University (JP)
Corresponding author
  • Kubota, Naoto
  • Kadowaki, Takashi
Venue
Nature Communications
Published
2016-10-06
Volume
7
Issue
1
Pages
12977-12977
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2529090544
Cited by
143
References
46
Citations by year
2026: 22 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 11 · 2021: 17 · 2020: 15 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 1
FWCI
3.96
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Takeda Science Foundation
  • Ministry of Education, Culture, Sports, Science and Technology (20229008, 18209033, 19591037, 16209030, 21390279)
  • Ono Medical Research Foundation
  • Japan Society for the Promotion of Science (16K15488, 16H05329, 26000012)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
IRS-1, insulin receptor substrate 2, liver zonation, periportal zone, perivenous zone, gluconeogenesis, lipogenesis, hyperinsulinemia, obesity, diabetes mellitus
MeSH terms
Animals, Cell Nucleus, Diabetes Mellitus, Diabetes Mellitus, Experimental, Gluconeogenesis, Homeostasis, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Obesity, Receptor, Insulin, Signal Transduction, Antigens, CD, Mice, Knockout, Mice, Insulin Receptor Substrate Proteins, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.